The CRISPR Atlas

Atlas API

이 사이트를 구성하는 것과 동일한 데이터베이스를 JSON으로 제공합니다. 출처 표기와 링크를 포함하면 비상업적 목적으로 무료로 이용할 수 있습니다. 응답을 캐시하고 요청 속도를 적절히 유지해 주세요.

Endpoints

Endpoint	Returns
/api/v1/stats	Record counts by kind, plus the number of graph connections.
/api/v1/entities?kind=…	All records of one kind, with status, evidence level and structured data. Kinds: `technology`, `disease`, `treatment`, `trial`, `company`, `scientist`, `gene`, `paper`, `institution`, `ethics`, `agriculture`, `learn`, `glossary`, `comparison`, `list`.
/api/v1/entity/{kind}/{slug}	One record in full, including body text, facts, sources and every related record in the knowledge graph.
/api/v1/trials?phase=&status=	The trial database, filterable by phase and status.
/api/v1/news?limit=40	Recent headlines with publisher and link. Article text stays with its publisher.
/api/search?term=…	Type-ahead search across every record kind.
/sitemap.xml	Every URL on the site, with last-modified dates.

Currently serving

17Technologies

19Diseases

15Treatments

14Clinical Trials

17Companies

12Scientists

19Genes

11Research

8Institutions

8Ethics

9Agriculture

26Learn

94Glossary

8Comparisons

11Lists & Rankings

Reading the fields

evidence — one of: Approved treatment, Clinical research, Preclinical research, Laboratory research, Future possibility. This is the field that tells you how seriously to take a claim.
status — regulatory or development stage (Approved, Phase III, Preclinical, Discontinued and so on), or trial recruitment status for trial records.
updated — when the record was last edited. Compiled data lags its sources; treat this as the age of the claim.
related — on single-entity responses, every connected record grouped by kind, with its relationship.

Terms

Attribution required: name The CRISPR Atlas and link to the page you took data from. Values are compiled from the public sources cited on each page and may be incomplete, delayed or revised — verify against the primary source before relying on them. The API carries no medical or investment advice and must not be presented as though it does. Access may be limited if usage threatens site availability.